MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient

Pasquale D'Alessandro1, Rocco Tritto2, Emanuela De Cillis1

  • 1Division of Heart Surgery, Department of Emergency & Organ Transplantation, University of Bari, Bari, Italy.

Future Cardiology
|September 21, 2022
PubMed

Hereditary hemorrhagic telangiectasia is regarded as a high hemorrhagic risk condition, and the management of anticoagulation and heart surgery in these patients can be challenging. The authors describe a combined percutaneous treatment of mitral regurgitation and left atrial appendage occlusion in a patient affected by hereditary hemorrhagic telangiectasia and atrial fibrillation, supporting the safety and feasibility of the procedure and the optimal short-term outcome.

Related Concept Videos